Pfizer: Antiviral pill cuts risk of coronavirus death, hospitalization by 89 percent

Pfizer announced on Friday that its antiviral COVID-19 pill cut the risk of coronavirus hospitalizations and deaths by 89 percent compared to those who received a placebo, according to an analysis of study data.The pharmaceutical company reported…